Lilly Korea raises doubts over survey of erectile dysfunction products

Lilly Korea has recently raised doubts over the reliability of Pfizer Korea’s report citing the survey on the treatment of PDE-5 inhibitors in patients with erectile dysfunction, which was released by Professor Park Nam-chul, Urology Department of Busan University.

Lilly Korea noted that the 59 ED patients involved for the survey is a smaller population unfit for eliciting significant diffe...